These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 13729934)

  • 21. Simplified recombinant plasmin: production and functional comparison of a novel thrombolytic molecule with plasma-derived plasmin.
    Hunt JA; Petteway SR; Scuderi P; Novokhatny V
    Thromb Haemost; 2008 Sep; 100(3):413-9. PubMed ID: 18766256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of large therapeutic doses of plasmin on fibrinogen and other plasma proteins.
    OUCHI H; SIMPSON RG; BELKO JS; WARREN R
    Surg Gynecol Obstet; 1961 Mar; 112():366-8. PubMed ID: 13731709
    [No Abstract]   [Full Text] [Related]  

  • 23. Probing the beta-chain hole of fibrinogen with synthetic peptides that differ at their amino termini.
    Doolittle RF; Pandi L
    Biochemistry; 2007 Sep; 46(35):10033-8. PubMed ID: 17688324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of plasmin activity by tranexamic acid does not influence inflammatory pathways during human endotoxemia.
    Renckens R; Weijer S; de Vos AF; Pater JM; Meijers JC; Hack CE; Levi M; van der Poll T
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):483-8. PubMed ID: 14739127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stability, sterility, coagulation, and immunologic studies of salmon coagulation proteins with potential use for mammalian wound healing and cell engineering.
    Laidmäe I; McCormick ME; Herod JL; Pastore JJ; Salum T; Sawyer ES; Janmey PA; Uibo R
    Biomaterials; 2006 Dec; 27(34):5771-9. PubMed ID: 16919721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incorporation of fragment X into fibrin clots renders them more susceptible to lysis by plasmin.
    Schaefer AV; Leslie BA; Rischke JA; Stafford AR; Fredenburgh JC; Weitz JI
    Biochemistry; 2006 Apr; 45(13):4257-65. PubMed ID: 16566600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The active center of human plasmin.
    RONWIN E
    Can J Biochem Physiol; 1962 Jan; 40():57-64. PubMed ID: 14493698
    [No Abstract]   [Full Text] [Related]  

  • 28. [The degradation products of human fibrinogen by plasmin. II. Immunological study: existence of native anti-fibrinogen antibodies possessing different specificities].
    NUSSENZWEIG V; SELIGMANN M; GRABAR P
    Ann Inst Pasteur (Paris); 1961 Apr; 100():490-508. PubMed ID: 13729933
    [No Abstract]   [Full Text] [Related]  

  • 29. The quantitative and clinical determination of human plasmin by the TAC method.
    RONWIN E
    Acta Haematol; 1961; 26():21-8. PubMed ID: 14493699
    [No Abstract]   [Full Text] [Related]  

  • 30. Probing the gamma2 calcium-binding site: studies with gammaD298,301A fibrinogen reveal changes in the gamma294-301 loop that alter the integrity of the "a" polymerization site.
    Kostelansky MS; Lounes KC; Ping LF; Dickerson SK; Gorkun OV; Lord ST
    Biochemistry; 2007 May; 46(17):5114-23. PubMed ID: 17411074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secreted protein acidic and rich in cysteine (SPARC/osteonectin/BM-40) binds to fibrinogen fragments D and E, but not to native fibrinogen.
    Wang H; Workman G; Chen S; Barker TH; Ratner BD; Sage EH; Jiang S
    Matrix Biol; 2006 Jan; 25(1):20-6. PubMed ID: 16263253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure and activity of plasmin and other direct thrombolytic agents.
    Novokhatny V
    Thromb Res; 2008; 122 Suppl 3():S3-8. PubMed ID: 18718639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The active center of plasmin.
    RONWIN E
    Biochim Biophys Acta; 1960 Feb; 38():258-65. PubMed ID: 14438696
    [No Abstract]   [Full Text] [Related]  

  • 34. Purification of components of the plasmin system.
    KLINE DL; FISHMAN JB
    Am J Cardiol; 1960 Aug; 6():387-9. PubMed ID: 14409880
    [No Abstract]   [Full Text] [Related]  

  • 35. Some aspects of the chemistry of plasmin and its inhibitors.
    NORMAN PS
    Am J Cardiol; 1960 Aug; 6():390-8. PubMed ID: 14427622
    [No Abstract]   [Full Text] [Related]  

  • 36. Adsorbed fibrinogen regulates the behavior of human dendritic cells in a CD18-dependent manner.
    Thacker RI; Retzinger GS
    Exp Mol Pathol; 2008 Apr; 84(2):122-30. PubMed ID: 18316072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasminogen and plasmin activity in patients with coronary artery disease.
    Drinane MC; Sherman JA; Hall AE; Simons M; Mulligan-Kehoe MJ
    J Thromb Haemost; 2006 Jun; 4(6):1288-95. PubMed ID: 16706973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study of plasmin in eye disease.
    UEMURA M; UEMURA Y; AKIYA S
    Am J Ophthalmol; 1962 Jul; 54():67-75. PubMed ID: 13923524
    [No Abstract]   [Full Text] [Related]  

  • 39. The differentiation of the chloroform, peptone and antigen-antibody inducible esterase activities of human serum from plasmin.
    AUSTEN KF
    Immunology; 1960 Apr; 3(2):152-73. PubMed ID: 13795183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
    Morange PE; Bickel C; Nicaud V; Schnabel R; Rupprecht HJ; Peetz D; Lackner KJ; Cambien F; Blankenberg S; Tiret L;
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2793-9. PubMed ID: 17023678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.